In a recent case-cohort study on a large registered cohort, Albanes et al. reported that increased insulin levels were associated with increased risks of prostate cancer (OR = 1.50–2.55 among compared insulin quartiles, P = 0.02) [35]. The gene discussed is INS; the disease is prostate carcinoma.